Log in


General Meeting: Updates in Pharmacy Research

  • April 09, 2020
  • 6:30 PM - 7:30 PM
  • Virtual Meeting (YouTube Livestream)

Registration

  • Members may attend for free

Register

Presented by:

 

ACPE # JA4008183-9999-20-019-L04-P / JA4008183-9999-20-019-L04-T

First-Time Offering; Initial Release Date Thursday, April 9, 2020

Successful completion of this activity counts as Live ACPE CE.

Topics / Speakers:
  • "Association Between ICU Opioid Use and Continuation Following Discharge" presented by Niki Krancevich, PharmD
  • "Efficacy & Safety of Apixaban/Rivaroxaban vs Warfarin for Atrial Fibrillation Treatment in Obese Patients" presented by Yoon Soo Park, PharmD
Time:

5:30 - 6:30 PM - Board Meeting

6:30 - 7:30 PM - Virtual CE Presentation

Organizer: Shelby Kelsh, PharmD
   

Livestream Info:

A link to the YouTube livestream will be emailed to registrants the evening before the event.  Those registering after that time will receive the link in their confirmation email. To access the chat features of the livestream, you will need to view the presentation while logged into YouTube with a Google account.

Requirements for successful completion of credit: Attendees will need to submit a provided CE Activity Code code within 12 hours of the activity in order to check-in for the activity. They will then have 30 days to log-in to their WMed Profile to complete the evaluation form and receive credit.

We recommend that you create a WMed account before attending one of our meetings.  Please see our Help Page for detailed instructions on creating a WMed account and claiming your CE credits.

After attending the program, the pharmacist and pharmacy technician should be able to:
    1. Discuss the risk factors for chronic or long-term opioid use. 

    2. Describe current guideline recommended practices for pain and sedation management in the ICU.

    3. Recognize weight and BMI values in which DOACs may not be preferred for stroke prophylaxis in patients with atrial fibrillation, and identify possible harms associated with initiating DOACs in patients weighing ≥120 kilograms and/or BMI ≥ 40 kg/m2.


    In support of improving patient care, this activity has been planned and implemented by Western Michigan University Homer Stryker M.D. School of Medicine and Western Michigan Society of Health-System Pharmacists. Western Michigan University Homer Stryker M.D. School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    Credit amount subject to change.

    Pharmacists & Pharmacy Technicians

    Western Michigan University Homer Stryker M.D. School of Medicine designates this activity for 1.0 contact hours for pharmacists and pharmacy technicians. Pharmacists and pharmacy technicians should claim only credit commensurate with the extent of their participation in the activity.

    Powered by Wild Apricot Membership Software